Related Posts
New World Metals Conference: Venture Minerals
10 Oct 2023 - Andrew Radonjic - Managing Director - Venture Minerals (ASX:VMS) is dedicated to discovering and developing world-class mineral deposits to meet global demand for critical minerals vital to the green energy transition.
Read More
IVE Group (ASX:IGL) FY20 results and outlook
27 Aug 2020 - IVE Group Limited (ASX:IGL) Executive Chairman Geoff Selig talks about FY20 results, the impact of COVID-19 on clients' marketing spend, group strategy and outlook.
Read More
Understanding credit investing with AL Capital
12 May 2025 - Phil Smith, a Director at AL Capital, discusses the company's strategy and focus on capital protection.
Read More
From Challenger to Revolution
17 June 2025 - How Bob Sahota turned a defensive credit philosophy into one of Australia’s most respected private debt funds.
Read More
PropTech Group (ASX:PTG) discusses Q3 FY22 results
17 May 2022 - PropTech Group Limited (ASX:PTG) Managing Director and Group CEO Joe Hanna discusses drivers behind PropTech's results, providing an update on the company's growth strategies.
Read More
Genetic Signatures (ASX:GSS) – detecting infectious diseases in high-throughput lab workflows
17 Nov 2022 - Genetic Signatures Limited (ASX:GSS) CEO and Director Dr John Melki discusses the company's technology, business model, 2022 highlights and outlook.
Read More
2024 RIU Explorers Conference Q&A with Q&A with Andrew Radonjic of Venture Minerals
04 Mar 2024 - Andrew Radonjic - Managing Director - Venture Minerals (ASX:VMS) is dedicated to discovering and developing world-class mineral deposits to meet global demand for critical minerals vital to the green energy transition.
Read More
Novatti Group (ASX:NOV) discusses growth opportunities in the payments sector
16 Apr 2021 - Novatti Group Limited (ASX:NOV) CEO Peter Cook talks about the growing demand for digital payments and the opportunities this presents for the company.
Read More
Gold, tech and growth
29 July 2025 - Sovereign Advisors Principal Advisor Zaheer Lalani and Investment Manager Max Riaz provide a quarterly update on the markets.
Read More
Radiopharm Theranostics (ASX:RAD) eyes NASDAQ listing
17 Feb 2023 - Radiopharm Theranostics Limited (ASX:RAD) CEO and Managing Director Riccardo Canevari discusses the company's upcoming plans to list on the NASDAQ and provides an update on the its clinical trials.
Read More